Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-19-009302
Filing Date
2019-05-09
Accepted
2019-05-09 16:09:27
Documents
69
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q oxfd20190331_10q.htm 10-Q 849377
2 EXHIBIT 31.1 ex_143002.htm EX-31.1 12000
3 EXHIBIT 31.2 ex_143003.htm EX-31.2 11879
4 EXHIBIT 32 ex_143004.htm EX-32 5678
  Complete submission text file 0001437749-19-009302.txt   4076541

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT oxfd-20190331.xml EX-101.INS 642927
6 XBRL TAXONOMY EXTENSION SCHEMA oxfd-20190331.xsd EX-101.SCH 48382
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE oxfd-20190331_cal.xml EX-101.CAL 61442
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE oxfd-20190331_def.xml EX-101.DEF 343589
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE oxfd-20190331_lab.xml EX-101.LAB 280031
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE oxfd-20190331_pre.xml EX-101.PRE 367358
Mailing Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ
Business Address 94C INNOVATION DRIVE MILTON PARK ABINGDON X0 OX14 4RZ 44 01235 442780
Oxford Immunotec Global PLC (Filer) CIK: 0001586049 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36200 | Film No.: 19810598
SIC: 2835 In Vitro & In Vivo Diagnostic Substances